{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:05:32Z","timestamp":1783098332110,"version":"3.54.6"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"This work was supported by the Luzhou Municipal Government-Southwest Medical University Joint Fund","award":["2021LZXNYD-J16"],"award-info":[{"award-number":["2021LZXNYD-J16"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>\n                    Although the Systemic Immune-Inflammation Index (SII) has established prognostic value in several diseases, its role in hepatitis B virus (HBV) infection remains undefined. HBV-related inflammation drives progression to cirrhosis, hepatic failure, and hepatocellular carcinoma. However, the association between SII and all-cause mortality in this population has not been well established. Therefore, our study aims to investigate the association of SII with all-cause mortality in patients with HBV infection. We retrospectively analyzed a cohort of US adults (\u226518 years) with HBV infection from the 1999 to 2018 National Health and Nutrition Examination Survey, focusing specifically on HBeAg-positive individuals. All-cause mortality (ascertained through the National Death Index as of December 2018) was evaluated in relation to SII using multivariable Cox regression with restricted cubic splines. Prognostic accuracy was evaluated using time-dependent receiver operating characteristic analysis, complemented by Kaplan\u2013Meier survival estimates. Subgroup and sensitivity analyses verified the robustness of the results against potential confounders. The cohort comprised 3332 HBV-infected individuals followed for a mean 105.83\u2005\u00b1\u200565.21 months, during which 682 all-cause mortality events were recorded. In the fully adjusted Cox model, a higher Log-Transformed Systemic Immune-Inflammation Index (lnSII) level remained independently associated with a significant 53% increase in all-cause mortality (hazard ratio\u2005=\u20051.53, 95% confidence interval: 1.13\u20132.08). Restricted cubic spline regression confirmed a dose-dependent positive association between lnSII and mortality (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001). Time-dependent receiver operating characteristic analysis demonstrated sustained high discriminatory accuracy across all intervals (area under the curve: 0.895 at 1-year, 0.874 at 3-year, 0.870 at 5-year, 0.868 at 10-year). Subgroup analyses revealed pronounced risk amplification among Hispanic individuals (hazard ratio\u2005=\u20052.90, 95% confidence interval: 1.14\u20137.38), while a U-shaped mortality relationship manifested in the low hepatic fibrosis stratum (Fibrosis-4 index\u2005&lt;\u20051.30;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.006), with optimal survival at lnSII\u2005=\u20056. Robustness was confirmed through extensive sensitivity analyses. Elevated SII is an independent predictor of all-cause mortality in HBV-infected patients, with the greatest risk in the top quartile. Its consistent accuracy for both short- and long-term outcomes calls for integrating this marker into clinical practice to improve risk-stratified management.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046305","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:00:15Z","timestamp":1764972015000},"page":"e46305","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Systemic immune-inflammation index as a predictor of all-cause mortality in patients with hepatitis B virus infection: A cross-sectional study based on NHANES 1999 to 2018"],"prefix":"10.1097","volume":"104","author":[{"given":"Min","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, The Affiliated Hospital of Southwest Medical University, Jiangyang District, Luzhou, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Affiliated Hospital of Southwest Medical University, Jiangyang District, Luzhou, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiameng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Affiliated Hospital of Southwest Medical University, Jiangyang District, Luzhou, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qiang","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Affiliated Hospital of Southwest Medical University, Jiangyang District, Luzhou, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5288-5486","authenticated-orcid":false,"given":"Gang","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, The Affiliated Hospital of Southwest Medical University, Jiangyang District, Luzhou, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","article-title":"Molecular biology of hepatitis B virus infection.","volume":"479-480","author":"Seeger","year":"2015","journal-title":"Virology"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","article-title":"Global burden of hepatitis B virus: current status, missed opportunities and a call for action.","volume":"20","author":"Hsu","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2147\/CLEP.S389853","article-title":"Global patterns and trends in total burden of hepatitis b from 1990 to 2019 and predictions to 2030.","volume":"14","author":"Zhang","year":"2022","journal-title":"Clin Epidemiol"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"391","DOI":"10.33073\/pjm-2020-044","article-title":"Hepatitis B virus: from diagnosis to treatment.","volume":"69","author":"Guvenir","year":"2020","journal-title":"Pol J Microbiol"},{"key":"R5-20260523","first-page":"4971","article-title":"Hepatitis B eradication: vaccine as a key player.","volume":"15","author":"Pujol","year":"2023","journal-title":"Am J Transl Res"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/vaccines12030288","article-title":"Global perspectives on the hepatitis b vaccination: challenges, achievements, and the road to elimination by 2030.","volume":"12","author":"Al-Busafi","year":"2024","journal-title":"Vaccines"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission.","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"773","DOI":"10.15585\/mmwr.mm6728a2","article-title":"Access to treatment for hepatitis B virus infection \u2013 worldwide, 2016.","volume":"67","author":"Hutin","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.3390\/v14102275","article-title":"Innate immunity, inflammation, and intervention in HBV infection.","volume":"14","author":"Yang","year":"2022","journal-title":"Viruses"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3748\/wjg.v30.i10.1295","article-title":"Overview of the immunological mechanisms in hepatitis B virus reactivation: implications for disease progression and management strategies.","volume":"30","author":"Ma","year":"2024","journal-title":"World J Gastroenterol"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4103\/tjem.tjem_198_23","article-title":"Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: an extensive literature review.","volume":"24","author":"Islam","year":"2024","journal-title":"Turkish J Emerg Med"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3389\/fimmu.2019.00973","article-title":"Dysfunctional immune response in acute-on-chronic liver failure: it takes two to tango.","volume":"10","author":"Martin-Mateos","year":"2019","journal-title":"Front Immunol"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"2492371","DOI":"10.1080\/21505594.2025.2492371","article-title":"Innate immune recognition in hepatitis B virus infection.","volume":"16","author":"Li","year":"2025","journal-title":"Virulence"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"805625","DOI":"10.3389\/fmolb.2021.805625","article-title":"Cytokines and chemokines in HBV infection.","volume":"8","author":"Zhong","year":"2021","journal-title":"Front Mol Biosci"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/nm1317","article-title":"Platelets mediate cytotoxic T lymphocyte-induced liver damage.","volume":"11","author":"Iannacone","year":"2005","journal-title":"Nat Med"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"1206720","DOI":"10.3389\/fcimb.2023.1206720","article-title":"Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity.","volume":"13","author":"Zheng","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12016-014-8465-4","article-title":"Cytokine-mediated immunopathogenesis of hepatitis B virus infections.","volume":"50","author":"Li","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"10721","DOI":"10.3748\/wjg.v21.i38.10721","article-title":"Restoring homeostasis of CD4\u207a T cells in hepatitis-B-virus-related liver fibrosis.","volume":"21","author":"Cheng","year":"2015","journal-title":"World J Gastroenterol"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-024-00722-6","article-title":"The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy.","volume":"13","author":"He","year":"2025","journal-title":"Biomark Res"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/JIR.S402227","article-title":"Association of systemic immune inflammation index with all-cause, cardiovascular disease, and cancer-related mortality in patients with cardiovascular disease: a cross-sectional study.","volume":"16","author":"Xiao","year":"2023","journal-title":"J Inflamm Res"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"21535","DOI":"10.1038\/s41598-024-72447-3","article-title":"Association between systemic immune inflammation index and short term prognosis of acute on chronic liver failure.","volume":"14","author":"Ma","year":"2024","journal-title":"Sci Rep"},{"key":"R22-20260523","first-page":"6841","article-title":"Predictive effect of systemic immune inflammatory index combined with neutrophil-to-lymphocyte ratio on prognosis of patients with acute-on-chronic liver failure.","volume":"15","author":"He","year":"2023","journal-title":"Am J Transl Res"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"100826","DOI":"10.1016\/j.lana.2024.100826","article-title":"Association of hepatitis B virus treatment with all-cause and liver-related mortality among individuals with HBV and cirrhosis: a population-based cohort study.","volume":"36","author":"Makuza","year":"2024","journal-title":"Lancet Regional Health Am"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1047-2797(01)00285-X","article-title":"A primer and comparative review of major US mortality databases.","volume":"12","author":"Cowper","year":"2002","journal-title":"Ann Epidemiol"},{"key":"R25-20260523","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection.","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"R26-20260523","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value.","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"R27-20260523","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ni.2691","article-title":"Immune surveillance by the liver.","volume":"14","author":"Jenne","year":"2013","journal-title":"Nat Immunol"},{"key":"R28-20260523","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/cmi.2014.79","article-title":"The immune tolerant phase of chronic HBV infection: new perspectives on an old concept.","volume":"12","author":"Bertoletti","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"R29-20260523","doi-asserted-by":"crossref","first-page":"20160274","DOI":"10.1098\/rstb.2016.0274","article-title":"Viral hepatitis and liver cancer.","volume":"372","author":"Ringelhan","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R30-20260523","doi-asserted-by":"crossref","first-page":"625472","DOI":"10.3389\/fimmu.2021.625472","article-title":"The roles of neutrophils in the pathogenesis of liver diseases.","volume":"12","author":"Tang","year":"2021","journal-title":"Front Immunol"},{"key":"R31-20260523","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/hep.28526","article-title":"Platelets: no longer bystanders in liver disease.","volume":"64","author":"Chauhan","year":"2016","journal-title":"Hepatology"},{"key":"R32-20260523","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2014.00258","article-title":"The role of natural killer cells and CD8(+) T cells in hepatitis B virus infection.","volume":"5","author":"Schuch","year":"2014","journal-title":"Front Immunol"},{"key":"R33-20260523","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer.","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat Med"},{"key":"R34-20260523","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.3748\/wjg.v23.i18.3228","article-title":"Platelets in liver disease, cancer and regeneration.","volume":"23","author":"Kurokawa","year":"2017","journal-title":"World J Gastroenterol"},{"key":"R35-20260523","doi-asserted-by":"crossref","first-page":"1169601","DOI":"10.3389\/fimmu.2023.1169601","article-title":"The role of regulatory T cells and follicular T helper cells in HBV infection.","volume":"14","author":"Lin","year":"2023","journal-title":"Front Immunol"},{"key":"R36-20260523","doi-asserted-by":"crossref","first-page":"1486503","DOI":"10.3389\/fmed.2024.1486503","article-title":"Association between the systemic immune-inflammation index and the outcome of liver fibrosis in patients with chronic hepatitis C.","volume":"11","author":"Ma","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R37-20260523","doi-asserted-by":"crossref","first-page":"e18571","DOI":"10.1097\/MD.0000000000018571","article-title":"Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: a meta-analysis.","volume":"99","author":"Wang","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"R38-20260523","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma.","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"R39-20260523","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance.","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"},{"key":"R40-20260523","doi-asserted-by":"crossref","first-page":"15499","DOI":"10.3748\/wjg.v20.i42.15499","article-title":"Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.","volume":"20","author":"M\u00f8ller","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R41-20260523","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1007\/s10620-021-07009-y","article-title":"Liver fibrosis in the natural course of chronic hepatitis B viral infection: a systematic review with meta-analysis.","volume":"67","author":"Lin","year":"2022","journal-title":"Dig Dis Sci"},{"key":"R42-20260523","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s44324-025-00063-4","article-title":"ECM formation and degradation during fibrosis, repair, and regeneration.","volume":"3","author":"Mayorca-Guiliani","year":"2025","journal-title":"NPJ Metab Health Dis"},{"key":"R43-20260523","doi-asserted-by":"crossref","first-page":"8061","DOI":"10.2147\/JIR.S490418","article-title":"The NRF-2\/HO-1 signaling pathway: a promising therapeutic target for metabolic dysfunction-associated steatotic liver disease.","volume":"17","author":"Li","year":"2024","journal-title":"J Inflamm Res"},{"key":"R44-20260523","doi-asserted-by":"crossref","first-page":"810286","DOI":"10.3389\/fimmu.2021.810286","article-title":"Duality of interactions between TGF-\u03b2 and TNF-\u03b1 during tumor formation.","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"R45-20260523","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrgastro.2010.213","article-title":"NF-\u03baB in the liver \u2013 linking injury, fibrosis and hepatocellular carcinoma.","volume":"8","author":"Luedde","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R46-20260523","first-page":"115","article-title":"Serum biomarkers for liver fibrosis assessment.","volume":"5","author":"Maroto-Garc\u00eda","year":"2024","journal-title":"Adv Lab Med"},{"key":"R47-20260523","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1515\/dmdi-2014-0023","article-title":"Pharmacogenetics of drug-metabolizing enzymes in US Hispanics.","volume":"30","author":"Claudio-Campos","year":"2015","journal-title":"Drug Metab Pers Ther"},{"key":"R48-20260523","doi-asserted-by":"crossref","first-page":"9649","DOI":"10.1007\/s11033-023-08894-4","article-title":"The importance of polymorphisms in the genes encoding glutathione S-transferase isoenzymes in development of selected cancers and cardiovascular diseases.","volume":"50","author":"Grussy","year":"2023","journal-title":"Mol Biol Rep"},{"key":"R49-20260523","doi-asserted-by":"crossref","first-page":"e0081","DOI":"10.1097\/HC9.0000000000000081","article-title":"Disparities in presentation and management of chronic hepatitis B among Hispanics in a diverse safety net system.","volume":"7","author":"Wang","year":"2023","journal-title":"Hepatol Commun"},{"key":"R50-20260523","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1161\/CIR.0000000000000534","article-title":"Cardiovascular health in African Americans: a scientific statement from the American heart association.","volume":"136","author":"Carnethon","year":"2017","journal-title":"Circulation"},{"key":"R51-20260523","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.cell.2020.06.045","article-title":"Trans-ethnic and ancestry-specific blood-cell genetics in 746,667 individuals from 5 global populations.","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"R52-20260523","doi-asserted-by":"crossref","first-page":"e1000360","DOI":"10.1371\/journal.pgen.1000360","article-title":"Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene.","volume":"5","author":"Reich","year":"2009","journal-title":"PLoS Genet"},{"key":"R53-20260523","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/CM9.0000000000002331","article-title":"Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the global burden of disease study.","volume":"135","author":"Cao","year":"2022","journal-title":"Chin Med J (Engl)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046305","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:00:41Z","timestamp":1779530441000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":53,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046305","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-07-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}